Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

rhoen-klinikum ag - RKAGY

RKAGY

Close Chg Chg %
7.55 -0.18 -2.38%

Closed Market

7.37

-0.18 (2.38%)

Volume: 200.00

Last Updated:

Jul 8, 2025, 3:16 PM EDT

Trade Now

Company Overview: rhoen-klinikum ag - RKAGY

RKAGY Key Data

Open

$7.31

 Day Range

7.31 - 7.37

52 Week Range

7.31 - 9.07

 Market Cap

$959.90M

Shares Outstanding

133.88M

 Public Float

N/A

Beta

0.06

 Rev. Per Employee

N/A

P/E Ratio

22.36

 EPS

$0.31

Yield

43.52%

 Dividend

$0.03

EX-DIVIDEND DATE

Jun 5, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

0.33

  

RKAGY Performance

No Data Available

RKAGY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Rhoen-klinikum Ag - RKAGY

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.86B 1.71B 1.81B 1.98B
Sales Growth
+6.73% -7.81% +5.43% +9.29%
Cost of Goods Sold (COGS) incl D&A
1.69B 1.55B 1.66B 1.79B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
82.43M 72.03M 70.47M 67.74M
Depreciation
76.40M 66.77M 65.28M 63.09M
Amortization of Intangibles
6.03M 5.25M 5.19M 4.65M
COGS Growth
+4.56% -8.25% +7.34% +7.86%
Gross Income
173.74M 167.71M 147.30M 184.76M
Gross Income Growth
+33.54% -3.47% -12.17% +25.43%
Gross Profit Margin
+9.34% +9.78% +8.15% +9.35%
2021 2022 2023 2024 5-year trend
SG&A Expense
166.67M 146.57M 168.14M 172.16M
Research & Development
- - - -
-
Other SG&A
166.67M 146.57M 168.14M 172.16M
SGA Growth
+10.37% -12.06% +14.72% +2.39%
Other Operating Expense
236.40K 315.29K 216.22K 216.34K
Unusual Expense
(1.71M) 12.25M (2.07M) 4.03M
EBIT after Unusual Expense
8.54M 8.57M (18.99M) 8.36M
Non Operating Income/Expense
27.47M 30.96M 74.56M 55.71M
Non-Operating Interest Income
582.72K 1.35M 11.37M 11.97M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
3.77M 4.28M 3.99M 3.40M
Interest Expense Growth
-55.22% +13.32% -6.74% -14.84%
Gross Interest Expense
3.77M 4.28M 3.99M 3.40M
Interest Capitalized
- - - -
-
Pretax Income
32.24M 35.26M 51.58M 60.68M
Pretax Income Growth
+635.47% +9.38% +46.27% +17.64%
Pretax Margin
+1.73% +2.06% +2.85% +3.07%
Income Tax
(3.39M) 7.03M 8.18M 11.90M
Income Tax - Current - Domestic
(2.80M) 6.29M 7.31M 6.92M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(590.99K) 735.68K 864.89K 4.98M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
35.73M 28.31M 43.43M 48.90M
Minority Interest Expense
2.28M 1.89M 1.57M 2.01M
Net Income
33.44M 26.43M 41.85M 46.89M
Net Income Growth
+1,921.89% -20.99% +58.38% +12.04%
Net Margin Growth
+1.80% +1.54% +2.31% +2.37%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
33.44M 26.43M 41.85M 46.89M
Preferred Dividends
- - - -
-
Net Income Available to Common
33.44M 26.43M 41.85M 46.89M
EPS (Basic)
0.2498 0.1974 0.3126 0.3503
EPS (Basic) Growth
+1,914.52% -20.98% +58.36% +12.06%
Basic Shares Outstanding
133.88M 133.88M 133.88M 133.88M
EPS (Diluted)
0.2498 0.1974 0.3126 0.3503
EPS (Diluted) Growth
+1,914.52% -20.98% +58.36% +12.06%
Diluted Shares Outstanding
133.88M 133.88M 133.88M 133.88M
EBITDA
89.26M 92.85M 49.41M 80.12M
EBITDA Growth
+53.86% +4.02% -46.78% +62.16%
EBITDA Margin
+4.80% +5.41% +2.73% +4.05%

Rhoen-Klinikum Ag in the News